Weill Cornell Medicine received a $1.5 million grant to develop new approaches for predicting the spread of cancer cells to the bone in men with prostate cancer, using tumor samples taken at early stages of the disease.
A gift totaling $25 million from Irwin M. Jacobs ’54, BEE ’56 and the Jacobs family includes a new $15 million commitment, adding to a $10 million commitment in 2023 that helped establish the center.
A new study emphasizes the importance of considering sex differences in Alzheimer’s research – a step that could ultimately lead to more precise and effective treatments.
The findings could lead to new treatments targeting a particular protein to better manage inflammation in patients who don’t respond well to existing therapies.
A two-day training program for the New York State Department of Homeland Security and Emergency Services helps local health officials and first responders convey key messages in a crisis.
A multidisciplinary team aims to build a more inclusive AI shaped by global cultures and knowledge – one of three projects that make up Cornell’s new GlobalGrand Challenge: The Future.
A new technology enables the control of specific brain circuits non-invasively with magnetic fields, according to a preclinical study from researchers at Weill Cornell Medicine, the Rockefeller University and the Icahn School of Medicine at Mount Sinai.
Many people enrolled in Medicaid who require psychiatric care have difficulty accessing clinicians in a timely manner despite the higher need in this population, according to a study by researchers at Weill Cornell Medicine.
A new preclinical model using CRISPR has given Weill Cornell Medicine researchers and their colleagues a deeper insight into how prostate cancer spreads or metastasizes.
Two Medicaid policies can interact to increase oncology clinical trial enrollment among Black and Hispanic patients, according to a new study by investigators at Weill Cornell Medicine, the University of Pennsylvania and Medidata AI.